Alpha-Mangosteen lessens high-fat/high-glucose diet and low-dose streptozotocin induced-hepatic manifestations in the insulin resistance rat model

References

• Akbar DH. 2003. Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome. Endocrine. 20(3):215–218.
   PubMed Web of Science ®Google Scholar
• Alwahsh SM, Dwyer BJ, Forbes S, Thiel DH, Lewis PJ, Ramadori G. 2017. Insulin production and resistance in different models of diet-induced obesity and metabolic syndrome. IJMS. 18(2):285.
   Google Scholar
• Ardakanian A, Ghasemzadeh Rahbardar M, Omidkhoda F, Razavi B, Hosseinzadeh H. 2022. Effect of alpha-mangostin on olanzapine-induced metabolic disorders in rats. Iranian J Basic Med Sci. 25:198–207.
   PubMed Web of Science ®Google Scholar
• Behrouz V, Dastkhosh A, Hedayati M, Sedaghat M, Sharafkhah M, Sohrab G. 2020. The effect of crocin supplementation on glycemic control, insulin resistance and active AMPK levels in patients with type 2 diabetes: a pilot study. Diabetol Metab Syndr. 12:59.
   PubMed Web of Science ®Google Scholar
• Chen X, Li X, Zhang W, He J, Xu B, Lei B, Wang Z, Cates C, Rousselle T, Li J. 2018. Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-κB pathway. Metabolism. 83:256–270.
   PubMed Web of Science ®Google Scholar
• Chopra I, Li HF, Wang H, Webster KA. 2012. Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle. Diabetologia. 55(3):783–794.
   PubMed Web of Science ®Google Scholar
• Entezari M, Hashemi D, Taheriazam A, Zabolian A, Mohammadi S, Fakhri F, Hashemi M, Hushmandi K, Ashrafizadeh M, Zarrabi A, et al. 2022. AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: a pre-clinical and clinical investigation. Biomed Pharmacother. 146:112563.
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Noshad S, Khalilzadeh O, Khalili M, Zandieh A, Nakhjavani M. 2011. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease. Metab Syndr Relat Disord. 9(2):111–117.
   PubMed Web of Science ®Google Scholar
• Fang Y, Su T, Qiu X, Mao P, Xu Y, Hu Z, Zhang Y, Zheng X, Xie P, Liu Q. 2016. Protective effect of alpha-mangostin against oxidative stress induced-retinal cell death. Sci Rep. 6:21018.
   PubMed Web of Science ®Google Scholar
• Gallagher EJ, Fierz Y, Vijayakumar A, Haddad N, Yakar S, LeRoith D. 2012. Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia. Oncogene. 31(27):3213–3222.
   PubMed Web of Science ®Google Scholar
• Garcia D, Shaw RJ. 2017. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell. 66(6):789–800.
   PubMed Web of Science ®Google Scholar
• Hardie DG, Ross FA, Hawley SA. 2012. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 13(4):251–262.
   PubMed Web of Science ®Google Scholar
• Herzig S, Shaw RJ. 2018. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 19(2):121–135.
   PubMed Web of Science ®Google Scholar
• Huang H, Lorenz BR, Zelmanovitz PH, Chan CB. 2021. Metformin preserves β-cell compensation in insulin secretion and mass expansion in prediabetic Nile rats. IJMS. 22(1):421.
   Google Scholar
• Kim JY, He F, Karin M. 2021. From liver fat to cancer: perils of the Western diet. Cancers. 13(5):1095.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Fujii N, Narita T, Higami Y. 2018. SREBP-1c-dependent metabolic remodeling of white adipose tissue by caloric restriction. IJMS. 19(11):3335.
   Google Scholar
• Lazarus G, Alexander S, Kusuma GO, Wijaya K, Soetikno V. 2020. Antioxidative activities of alpha-mangostin in high-fat/high-glucose diet and streptozotocin-induced insulin-resistant rodents. J Appl Pharm Sci. 10:035–039.
   Google Scholar
• Lee D, Kim YM, Jung K, Chin YW, Kang KS. 2018. Alpha-Mangostin improves insulin secretion and protects INS-1 cells from streptozotocin-induced damage. Int J Mol Sci. 19:1484.
   PubMed Web of Science ®Google Scholar
• Li RS, Xu GH, Cao J, Liu B, Xie HF, Ishii Y, Zhang CF. 2019. Alpha-Mangostin ameliorates bleomycin-induced pulmonary fibrosis in mice partly through activating adenosine 5′-monophosphate-activated protein kinase. Front Pharmacol. 10:1305.
   PubMed Web of Science ®Google Scholar
• Li L, Brunner I, Han AR, Hamburger M, Kinghorn AD, Frye R, Butterweck V. 2011. Pharmacokinetics of α-mangostin in rats after intravenous and oral application. Mol Nutr Food Res. 55: s 67–74.
   Web of Science ®Google Scholar
• Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY, et al. 2011. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13(4):376–388.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Manco M. 2017. Insulin resistance and NAFLD: a dangerous liaison beyond the genetics. Children. 4:74.
   PubMedGoogle Scholar
• Mechanick JI, Farkouh ME, Newman JD, Garvey WT. 2020. Cardiometabolic-based chronic disease, adiposity and dysglycemia drivers: JACC state-of-the-art review. J Am Coll Cardiol. 75(5):525–538.
   PubMed Web of Science ®Google Scholar
• Parkhe A, Parekh P, Nalla LV, Sharma N, Sharma M, Gadepalli A, Kate A, Khairnar A. 2020. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson’s disease. Neurosci Lett. 716:134652.
   PubMed Web of Science ®Google Scholar
• Pillon NJ, Croze ML, Vella RE, Soulère L, Lagarde M, Soulage CO. 2012. The lipid peroxidation by-product 4-hydroxy-2-nonenal (4-HNE) induces insulin resistance in skeletal muscle through both carbonyl and oxidative stress. Endocrinology. 153(5):2099–2111.
   PubMed Web of Science ®Google Scholar
• Ratwita W, Sukandar EY, Kurniati NF, Adnyana IK. 2018. Alpha mangostin and xanthone from mangosteen (Garcinia mangostana L.) role on insulin tolerance and PPAR-γ in preclinical model diabetes mellitus. J Pharm Nutr Sci. 8:83–90.
   Google Scholar
• Ratwita W, Sukandar EY, Adnyana IK, Kurniati NF. 2019. Alpha mangostin and xanthone activity on fasting blood glucose, insulin and Langerhans islet of Langerhans in alloxan-induced diabetic mice. PJ. 11(1):64–68.
   Google Scholar
• Saklayen MG. 2018. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 20(2):12.
   PubMed Web of Science ®Google Scholar
• Seki M, Miwa A, Ohsaka F, Karatsu Y, Tsuruta T, Hino S, Morita T, Sonoyama K. 2022. Local free fatty acids trigger the expression of lipopolysaccharide-binding protein in murine white adipose tissue. Biosci Microbiota Food Health. 41(2):54–65.
   PubMed Web of Science ®Google Scholar
• Shi Y, Fan Y, Hu Y, Jing J, Wang C, Wu Y, Geng Q, Dong X, Li E, Dong D. 2020. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades. J Cell Mol Medi. 24(1):760–771.
   PubMed Web of Science ®Google Scholar
• Shin MK, Yang SM, Han IS. 2020. Capsaicin suppresses liver fat accumulation in high-fat diet-induced NAFLD mice. Anim Cells Syst. 24(4):214–219.
   PubMed Web of Science ®Google Scholar
• Shurrab NT, E-SA, Arafa ESA. 2020. Metformin: a review of its therapeutic efficacy and adverse effects. Obesity Med. 17:100186.
   Google Scholar
• Sigit FS, Trompet S, Tahapary DL, Sartono E, Willems van Dijk K, Yazdanbakhsh M, Supali T, Smit JWA, Rosendaal FR, de Mutsert R. 2021. The associations of leptin and adiponectin with the metabolic syndrome in an Indonesian and a Dutch population. Nutr Metab Cardiovasc Dis. 31(8):2426–2435.
   PubMed Web of Science ®Google Scholar
• Soetikno V, Murwantara A, Andini P, Charlie F, Lazarus G, Louisa M, Arozal W. 2020. Alpha-mangostin improves cardiac hypertrophy and fibrosis and associated biochemical parameters in high-fat/high-glucose diet and low-dose streptozotocin injection-induced type 2 diabetic rats. J Exp Pharmacol. 12:27–38.
   PubMedGoogle Scholar
• Sun J, Wang Y, Zhang X, He H. 2019. The effects of metformin on insulin resistance in overweight or obese children and adolescents: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine. 98(4):e14249.
   PubMed Web of Science ®Google Scholar
• Tsai SY, Chung PC, Owaga EE, Tsai IJ, Wang PY, Tsai JI, Yeh TS, Hsieh RH. 2016. Alpha-mangostin from mangosteen (Garcinia mangostana Linn.) pericarp extract reduces high fat-diet induced hepatic steatosis in rats by regulating mitochondria function and apoptosis. Nutr Metab. 13:88.
   Google Scholar
• Wróbel MP, Marek B, Kajdaniuk D, Rokicka D, Szymborska-Kajanek A, Strojek K. 2017. Metformin- a new old drug. Endokrynol Pol. 68(4):482–496.
   PubMedGoogle Scholar
• Yap KH, Yee GS, Candasamy M, Tan SC, Md SA, Majeed AB, Bhattamisra SK. 2020. Catalpol ameliorates insulin sensitivity and mitochondrial respiration in skeletal muscle of type-2 diabetic mice through insulin signalling pathway and AMPK/SIRT1/PGC-1α/PPAR-γ activation. Biomolecules. 10(10):1360.
   PubMed Web of Science ®Google Scholar
• Yasmin T, Rahman MM, Khan F, Kabir F, Nahar K, Lasker S, Islam MD, Hossain MM, Hasan R, Rana S, et al. 2021. Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways. Biochem Biophys Rep. 28:101168.
   PubMedGoogle Scholar